Cifras calculadas a partir de notificaciones regulatorias oficiales — .
Datos financieros
ProfessionalIngresos, márgenes, ratio precio/beneficio y más con el plan Professional.
Pregúntale a la máquina
Busca y compara operaciones de iniciados, sociedades y sus estadísticas en lenguaje natural. Tu pregunta se convierte en una consulta sobre los datos disponibles, no en una conversación ni en asesoramiento de inversión.
Solo datos de EASTGATE BIOTECH CORP. Sin búsqueda web. Se excluyen las estadísticas globales de cada iniciado.
Una búsqueda ejecutada consume un crédito, incluso sin resultados. Los errores y las preguntas no compatibles no consumen créditos.
Eastgate Biotech Corp., a development stage company, develops novel formulations of natural compounds and pharmaceutical products. The company is developing pharmaceutical products, such as Lorazepam oral spray for acute seizures emergency treatment; Ketoconazole 2% topical ointment for treatment of skin fungal infections; and Metformin chewable/ sublingual tablets for treatment of type 2 diabetes. It is also developing natural products and dietary supplements, including E-drops Nano and PURALEN that are self-nanoemulsifying compositions containing natural essential oils for oral administration; Glucora, a soft gelatin capsule with Banaba extract in self-emulsifying formulation for oral administration; URBAN POWER, a soft gelatin capsule with Ursolic acid and Banaba extract in self-emulsifying formulation for oral administration; Vitamin D3 nanoemulsion, a nanoemulsion with cholecalciferol; and Cleanezze, a hand sanitizer containing oil. Eastgate Biotech Corp. has collaboration with Biotech Corp. to develop a vaccine against COVID-19. The company was formerly known as Eastgate Acquisitions Corporation and changed its name to Eastgate Biotech Corp. in December 2014. Eastgate Biotech Corp. was founded in 1999 and is based in Toronto, Canada.
Fuente de información de mercado · Sep 14, 2026
Periodos registrados en las fuentes consultadas. No certifican las fechas legales de los cambios de nombre.
Identidad según la SEC · Sep 14, 2026
Cronología en el mercado · historial completo
18 compras— precio de cierrebarra = volumen usd, escala √haz clic en un periodo para filtrar la tabla
| Iniciado | Tipo | Valor · USD | Detalle | |
|---|---|---|---|---|
| Lukian Brianhistorial | Compra | $41.5K | SEC | |
| SCHWARZ JOSEPH |
| Compra |
| $44.9K |
| SEC |
| GLUSKIN ANNA Ehistorial | CompraD (derivado) | $49.8K | SEC |
| WEISSPAPIR MICHAELhistorial | Compra | $44.9K | SEC |
| Hasanagic Mirjana Mirahistorial | CompraD (derivado) | $28.9K | SEC |
| WEISSPAPIR MICHAELhistorial | CompraD (derivado) | $44.9K | SEC |
| Hasanagic Mirjana Mirahistorial | Compra | $28.9 | SEC |
| GLUSKIN ANNA Ehistorial | Compra | $49.8K | SEC |
| SCHWARZ JOSEPHhistorial | CompraD (derivado) | $44.9K | SEC |
| Lukian Brianhistorial | CompraD (derivado) | $41.5K | SEC |
| WEISSPAPIR MICHAELhistorial | Compra | $38.2 | SEC |
| SCHWARZ JOSEPHhistorial | Compra | $38.2K | SEC |
| GLUSKIN ANNA Ehistorial | Compra | $120K | SEC |
| Hasanagic Mirjana Mirahistorial | CompraD (derivado) | $51.3K | SEC |
| Lukian Brianhistorial | Compra | $106.8K | SEC |
| TGT INVESTMENT MANAGEMENT INC. | CompraD (derivado) | $80.1K | SEC |
| Hasanagic Mirjana Mirahistorial | Compra | $68.4K | SEC |
| TGT INVESTMENT MANAGEMENT INC. | Compra | $106.8K | SEC |
| WEISSPAPIR MICHAELhistorial | CompraD (derivado) | $9K | SEC |
| Lukian Brianhistorial | CompraD (derivado) | $80.1K | SEC |
| WEISSPAPIR MICHAELhistorial | Compra | $47K | SEC |
| GLUSKIN ANNA Ehistorial | CompraD (derivado) | $90K | SEC |
| SCHWARZ JOSEPHhistorial | Compra | $47K | SEC |
| SCHWARZ JOSEPHhistorial | CompraD (derivado) | $9K | SEC |
| Lukian Brianhistorial | CompraD (derivado) | $135K | SEC |